KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nov (NOV) Asset Writedowns and Impairment (2016 - 2020)

Historic Asset Writedowns and Impairment for Nov (NOV) over the last 5 years, with Q1 2020 value amounting to $513.0 million.

  • Nov's Asset Writedowns and Impairment changed N/A to $513.0 million in Q1 2020 from the same period last year, while for Dec 2020 it was $513.0 million, marking a year-over-year decrease of 7677.68%. This contributed to the annual value of $70.0 million for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q1 2020, Nov's Asset Writedowns and Impairment is $513.0 million.
  • Nov's Asset Writedowns and Impairment's 5-year high stood at $2.2 billion during Q2 2019, with a 5-year trough of $10.0 million in Q4 2019.
  • Its 3-year average for Asset Writedowns and Impairment is $738.8 million, with a median of $513.0 million in 2020.
  • Data for Nov's Asset Writedowns and Impairment shows a peak YoY increase of 166727.27% (in 2016) and a maximum YoY decrease of 166727.27% (in 2016) over the last 5 years.
  • Nov's Asset Writedowns and Impairment (Quarter) stood at $972.0 million in 2016, then plummeted by 98.97% to $10.0 million in 2019, then surged by 5030.0% to $513.0 million in 2020.
  • Its Asset Writedowns and Impairment was $513.0 million in Q1 2020, compared to $10.0 million in Q4 2019 and $12.0 million in Q3 2019.